A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2015; you can also visit the original URL.
The file type is application/pdf
.
Filters
Applying linked data approaches to pharmacology: Architectural decisions and implementation
2014
Semantic Web Journal
In this application report, we describe a linked data platform for integrating multiple pharmacology datasets that form the basis for several drug discovery applications. ...
The discovery of new medicines requires pharmacologists to interact with a number of information sources ranging from tabular data to scientific papers, and other specialized formats. ...
of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. ...
doi:10.3233/sw-2012-0088
fatcat:l5vohyessjejbbbrvb62vcoyzu
Agent-Based Modeling in Systems Pharmacology
2015
CPT: Pharmacometrics & Systems Pharmacology
Modeling and simulation (M&S) techniques provide a platform for knowledge integration and hypothesis testing to gain insights into biological systems that would not be possible a priori. ...
This tutorial introduces ABM to systems pharmacologists, using relevant case studies to highlight how ABM-specific strengths have yielded success in the area of preclinical mechanistic modeling. ...
The first two authors contributed equally to this work. Partly funded by the Wellcome Trust ...
doi:10.1002/psp4.12018
pmid:26783498
pmcid:PMC4716580
fatcat:kf7lhaq7hbcb3li5queac5yjam
Genomic architecture of pharmacological efficacy and adverse events
2014
Pharmacogenomics (London)
Pharmacogenomics-based tests are already being applied in clinical decision making. ...
The pharmacokinetic and pharmacodynamic disciplines address pharmacological traits, including efficacy and adverse events. ...
Acknowledgments The authors thank the Pharmacogenomics Research Network (PGRN) and its trans-network project on 'Polygenic ...
doi:10.2217/pgs.14.144
pmid:25521360
pmcid:PMC4308414
fatcat:harmjdduwzfzhjli4kb3fvnfsm
Implementation of Quantitative and Systems Pharmacology in Large Pharma
2014
CPT: Pharmacometrics & Systems Pharmacology
and experimental methods to elucidate, validate, and apply new pharmacological concepts to the development and use of small molecule and biologic drugs. 8 A unique feature of quantitative and systems ...
A focus on the development of system-level (mathematical) models through the integration of experimental data and knowledge has led to an improved understanding of human biology, pharmacology, and safety ...
The authors thank all our colleagues from Merck and our external collaborators, who have contributed to the countless study and modeling activities, to the implementation and to its associated impact as ...
doi:10.1038/psp.2014.40
pmid:25338195
pmcid:PMC4474169
fatcat:4ll7iteqvnes5kjenlxhcd5434
Harnessing Big Data for Systems Pharmacology
[article]
2016
bioRxiv
pre-print
Here, we discuss several upcoming issues in systems pharmacology and potential solutions to them using big data technology. ...
Data-driven modeling plays a central role in systems pharmacology, and has already enabled biologists to generate novel hypotheses. However, more is needed. ...
(A) Architecture of model management systems. Models are linked with associated data sets, metadata and software that is wrapped within a container and accessed through a model commons. ...
doi:10.1101/077115
fatcat:owkyissq65agrdovh2vdgux24m
Toward an integrated software platform for systems pharmacology
2013
Biopharmaceutics & drug disposition
This is particularly true for systems pharmacology, which aims to understand the action of drugs and their interactions in a systems context. ...
Software platforms play a dominant role in creativity and productivity support and have transformed many industries, techniques that can be applied to biology as well. ...
pharmacology (QSP), defined as '.. as an approach to translational medicine that combines computational and experimental methods to elucidate, validate and apply new pharmacological concepts to the development ...
doi:10.1002/bdd.1875
pmid:24150748
pmcid:PMC4253131
fatcat:l4dvxrd4qzeqro75ysop35j4b4
Global mapping of pharmacological space
2006
Nature Biotechnology
Using the data matrix, we are able to catalog the links between proteins in chemical space as a polypharmacology interaction network. ...
The relationships between proteins, chemical structures and drug-like properties provide a framework for developing a probabilistic approach to drug discovery that can be exploited to increase research ...
Thus, both chemoinformatics and bioinformatics techniques can be applied directly to the data-mining of the integrated data set. ...
doi:10.1038/nbt1228
pmid:16841068
fatcat:axmif2jgqvhp7lgn27khjslw4i
Harnessing Big Data for Systems Pharmacology
2017
Annual Review of Pharmacology and Toxicology
Beyond the data challenge, models are strongly coupled with algorithms underlying the model, software that implements the algorithm to execute the model, and tools that process inputs and outputs. ...
Here, we discuss several upcoming issues in systems pharmacology and potential solutions to them using big data technology. ...
(A) Architecture of model management systems. Models are linked with associated data sets, metadata and software that is wrapped within a container and accessed through a model commons. ...
doi:10.1146/annurev-pharmtox-010716-104659
pmid:27814027
pmcid:PMC5626567
fatcat:oajwecyapvbghjgft2wizxoeze
Electronic Medical Records as a Tool in Clinical Pharmacology: Opportunities and Challenges
2012
Clinical Pharmacology and Therapeutics
in the fields of basic, translational, and implementation sciences. ...
more sophisticated, and links being established with DNA repositories. ...
Emr-basEd disCovEry in CliniCal pharmaCology approach to Emr-based phenotyping A common experimental design starts with construction of a cohort of cases and controls for a specific phenotype (e.g., a ...
doi:10.1038/clpt.2012.42
pmid:22534870
pmcid:PMC3819803
fatcat:wa366oirjrdltdpzrdp5gblhtm
Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review)
2016
Oncology Reports
Development of PBPK models and advanced ex vivo pharmacological assays to support PTx and implement clinical pharmacology guidelines 4. ...
The economic burden and cost-effectiveness of PGx to enable personalized cancer medicine decisions 3. ...
ADME) and v) innovative approaches and tools on patient electronic data Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics ...
doi:10.3892/or.2016.4575
pmid:26781205
fatcat:vrkndmrwb5biboijnaqw4p5jwe
Poster Session (abstracts)
1992
Fundamental & Clinical Pharmacology
Additional tools and modules allow the user to assess risk and implement necessary control methods prior to bringing the material on site, thus allowing for educated decision making with respect to nanomaterial ...
The Service-Oriented, federated approaches developed for the DoD can also be adopted and applied to nanoinformatics supporting the nanotechnology domain. ...
doi:10.1111/j.1472-8206.1992.tb00143.x
fatcat:zcx4fjes2bdy7doigfmdonkgea
Predicting protein-ligand interactions based on bow-pharmacological space and Bayesian additive regression trees
2019
Scientific Reports
The algorithm applies Bayesian Additive Regression Trees (BART) on a newly proposed proteochemical space, termed the bow-pharmacological space. ...
For the rapid identification of protein-ligand interactions, we here present a novel chemogenomics algorithm for the prediction of protein-ligand interactions using a new machine learning approach and ...
We thank Etienne Caron and Lorenz Blum for reading the manuscript drafts and providing comments. ...
doi:10.1038/s41598-019-43125-6
pmid:31118426
pmcid:PMC6531441
fatcat:5ivfmrrq55bklnmtfok2rjrc64
History and Future Perspectives on the Discipline of Quantitative Systems Pharmacology Modeling and Its Applications
2021
Frontiers in Physiology
With an increased focus on the pharmacology application of system models and the advances in data science spanning mechanistic and empirical approaches, there is a significant opportunity and promise to ...
In this paper, we will review milestones in the evolution of mathematical biology and pharmacology models, highlight some of the gaps and challenges in developing and applying systems pharmacology models ...
When a decision is made to invest in building a QSP model, several approaches can be implemented, depending on the modeling scope and the available data. ...
doi:10.3389/fphys.2021.637999
pmid:33841175
pmcid:PMC8027332
fatcat:bfy3cijfqjceth3zk276bqtwem
Pharmacologic Management of Aneurysms
2019
Circulation Research
Preclinical studies in the context of abdominal aortic aneurysm identified hundreds of candidate strategies for stabilization, and data from preoperative clinical intervention studies show that interventions ...
Preclinical models more reflective of human pathophysiology, identification of biomarkers to predict severity of disease progression, and improved design of clinical trials may more rapidly advance the ...
Research grant funding to University of Wisconsin (Dr Matsumura): Abbott, Gore, Endologix, Cook, Medtronic, and NIH. ...
doi:10.1161/circresaha.118.312439
pmid:30763216
pmcid:PMC6386187
fatcat:obojnm5vdzckrlr4jg7lkwq3pm
Prerequisites to Implementing a Pharmacogenomics Program in a Large Health-Care System
2014
Clinical Pharmacology and Therapeutics
A multifaceted approach was applied. We invited nationally known experts to take part in a symposium to address clinical implementation challenges. ...
CPIC guidelines on gene/drug pairs were used to help select targeted medications and the micro-array architecture. Decisions were based on the clinical evidence associated with each reportable SNP. ...
doi:10.1038/clpt.2014.101
pmid:24807457
pmcid:PMC4441093
fatcat:ui5qvfibanenncfg22jygw6sbm
« Previous
Showing results 1 — 15 out of 7,549 results